Annual report [Section 13 and 15(d), not S-K Item 405]

ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)

v3.25.1
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS (Details)
$ in Thousands
 1 Months Ended 12 Months Ended
Dec. 04, 2024
USD ($)
Aug. 31, 2023
USD ($)
Jan. 26, 2023
USD ($)
Dec. 31, 2024
USD ($)
Dec. 31, 2024
USD ($)
shares
Dec. 31, 2023
USD ($)
shares
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Number of approved prescription drugs for dermatological conditions         8  
Cash and cash equivalents       $ 20,305 $ 20,305 $ 27,439
Working capital       13,000 13,000 14,600
Cash received from recovery of fund $ 4,600     $ 4,600    
Stock issued value         $ 7,877 $ 4,494
Common Stock            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Stock issued value     $ 150,000      
Stock issued (in shares) | shares         1,564,310 748,703
New License Agreement            
ORGANIZATION AND PLAN OF BUSINESS OPERATIONS            
Proceeds from non-refundable payment   $ 19,000